Correction: 2022 Clinical Practice Guideline Update for Diabetes Management of Chronic Kidney Disease

In the editorial by Saunders and Laiteerapong (1), the editorialists incorrectly stated that Kidney Disease: Improving Global Outcomes (KDIGO) collaborated with the American Diabetes Association for the guidelines. It would have been more accurate to say that KDIGO and the American Diabetes Association have collaborated on a consensus report on diabetes management in chronic kidney disease. The text has been revised to read, “Although it is helpful that KDIGO and the American Diabetes Association have a consensus report on diabetes management in chronic kidney disease … ,” and a reference has been added to reflect this revision (2).

1. Saunders M, Laiteerapong N. 2022 clinical practice guideline update for diabetes management of chronic kidney disease: an important first step, more work to do. Ann Intern Med. 10 January 2023. [Epub ahead of print].. [PMID: 36623285] doi:10.7326/M22-3635 LinkGoogle Scholar2. de Boer IH, Khunti K, Sadusky T, et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2022;102:974-89. [PMID: 36202661] doi:10.1016/j.kint.2022.08.012 CrossrefMedlineGoogle Scholar

留言 (0)

沒有登入
gif